Results per Page:
Measure 170 times, cut once: high-throughput drug screening for multiple myeloma
From Dr. Pamela Becker and Dr. David Coffey, Clinical Research Division
Targeted therapies push metastatic prostate cancer in new directions
Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments